688566 Jiangsu Jibeier Pharmaceutical Co., Ltd.
- 24.78
- +0.60+2.48%
Jiangsu Jibeier Pharmaceutical Co., Ltd. News
Gibel\'s equity distribution implementation announcement for the first three quarters of 2024
Gibbel: Gibel\'s profit distribution plan announcement for the first three quarters of 2024
Gibbel: Q3 2024 Report
Gibbel: Guojin Securities Co., Ltd.\'s inspection opinion on the foreign investment and related transactions of Jiangsu Gibel Pharmaceutical Co., Ltd.
Gibbel: Announcement of Resolutions of the 11th Meeting of the Fourth Board of Supervisors of Gibbel
Gibbel: Gibel\'s announcement on foreign investment and related transactions
Gibbel: Independent Opinions of Independent Directors of Jiangsu Jebel Pharmaceutical Co., Ltd. on matters related to the 12th meeting of the 4th Board of Directors
Announcement of Resolutions of the 11th Meeting of the Fourth Board of Supervisors of Gibbel
Independent opinions of independent directors of Jiangsu Jebel Pharmaceutical Co., Ltd. on matters related to the 12th meeting of the fourth board of directors
Gibel\'s profit distribution plan announcement for the first three quarters of 2024
Guojin Securities Co., Ltd. inspection opinions on foreign investment and related transactions of Jiangsu Gibel Pharmaceutical Co., Ltd.
Gibel\'s announcement on foreign investment and related transactions
Gibel 2024 Third Quarter Report
Gibbel: Gibel\'s Voluntary Disclosure Notice on Obtaining Patents for Inventions
Gibel\'s Voluntary Disclosure Notice on Obtaining Invention Patents
Gibel\'s announcement on changing the registered capital of the company and amending the “Articles of Association”
Gibert\'s “Articles of Association” (revised in September 2024)
Jiangsu Gibel Pharmaceutical Co., Ltd. Investor Relations Activity Record Form (2024 Semi-Annual Results Briefing)
Jiangsu Gibel Pharmaceutical Co., Ltd. Investor Relations Activity Record Form September 18, 2024
Gibbel\'s announcement on the results of the third vesting period of the 2021 Restricted Stock Incentive Plan and stock listing
Analysis
Price Target
No Data
No Data